Postpartum outcomes in sickle cell disease: transfusion exposure, maternal morbidity, and breastfeeding persistence
Journal of Perinatal Medicine · 25.11.2026 · 54 (9) · 1424-1432
DOI: 10.1515/jpm-2026-0271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Perinatal Medicine, online erschienen am 18.09.2026. Verfasst von Nawras Zayat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology and Women's Health, Montefiore Medical Center, Albert Einstein College of …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Breast Feeding, Blood Transfusion, Pregnancy Complications, Hematologic. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Hebammenwesen und Geburtshilfe, Stillen
Abstract (Originalsprache)
Objectives
To characterize postpartum maternal morbidity in women with sickle cell disease (SCD) and explore whether antepartum disease burden, transfusion exposure, and peripartum clinical factors were associated with postpartum maternal and breastfeeding outcomes.
Methods
We conducted a retrospective cohort study of 37 deliveries in patients with confirmed SCD at a large urban academic center (2015–2025). Maternal, neonatal, transfusion, and breastfeeding outcomes were abstracted from the electronic medical record.
Results
Thirty-seven deliveries met inclusion criteria. The predominant genotype was HbSS (24/37, 64.9 %), followed by HbSC (7/37), HbSβ 0 -thalassemia (3/37), HbSβ + -thalassemia (2/37), and HbS/HPFH (1/37). More than one-third of deliveries (13/37, 35.1 %) required transfusion within the first postpartum week. Postpartum hemorrhage ≥1,000 mL occurred in 5 of 37 deliveries (13.5 %), and 5 of 36 (13.9 %) required readmission within 6 weeks postpartum, most commonly for vaso-occlusive crisis. NICU admission occurred in 14 of 37 neonates (37.8 %). Breastfeeding intention was high (32/33, 97 %); persistence declined to 23 of 33 (69.7 %) at 6 weeks and 12 of 34 (35.3 %) at approximately 6 months. Exploratory analyses suggested lower breastfeeding persistence among deliveries complicated by NICU admission and among those with greater antepartum clinical burden, including pregnancy transfusion, lower admission hemoglobin, and hospitalization during pregnancy.
Conclusions
The postpartum period in women with SCD is characterized by persistent hematologic morbidity, ongoing transfusion requirements, and declining breastfeeding persistence. Greater antepartum disease burden and neonatal complications may identify pregnancies at higher risk for adverse postpartum outcomes, supporting integrated hematology-obstetric care extending into the postpartum period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology and Women's Health, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
- Division of Hematology, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
- Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
ORCID-Profile: Nawras Zayat
Zitieren
APA
Zayat, N., Bertuzzi, R., Eckman, J., & Billett, H. (2026). Postpartum outcomes in sickle cell disease: transfusion exposure, maternal morbidity, and breastfeeding persistence. Journal of Perinatal Medicine, 54(9), 1424-1432. https://doi.org/10.1515/jpm-2026-0271
Vancouver
Zayat N, Bertuzzi R, Eckman J, Billett H. Postpartum outcomes in sickle cell disease: transfusion exposure, maternal morbidity, and breastfeeding persistence. Journal of Perinatal Medicine. 2026;54(9):1424-1432. doi:10.1515/jpm-2026-0271
BibTeX
@article{Zayat2026,
author = {Zayat, Nawras and Bertuzzi, Rachael and Eckman, Jared and Billett, Henny},
title = {Postpartum outcomes in sickle cell disease: transfusion exposure, maternal morbidity, and breastfeeding persistence},
journal = {Journal of Perinatal Medicine},
year = {2026},
volume = {54},
number = {9},
pages = {1424--1432},
doi = {10.1515/jpm-2026-0271}
}
EUVIMED